Alert your patients of a counterfeit form of emergency contraception (EC), labeled as Evital. The Food and Drug Administration (FDA) has issued a warning on the drug.
The Food and Drug Administration (FDA) added a "black box" warning in 2004 to the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City; Medroxyprogesterone Acetate Injectable Suspension USP, Teva Pharmaceuticals USA, North Wales, PA) advising that prolonged use might result in bone mineral density loss.
Field test results of a integrated microfluidic-based diagnostic device indicate that the potential "lab-on-a-chip" might be able to perform complex laboratory assays in a simple, convenient manner.
My emergency department (ED) has had an electronic medical record for the past two years. Part of that record includes a medication list that is created from past encounters and updated by the triage nurse. Because it is electronic and prints out nicely in the triage summary, it has the appearance of truth. My experience with the list is likely similar to some of yours: Patients are often taking medications not on the list and are not currently taking those that are.
This is the second part of our two-part series on complications of tubes and lines. This issue deals with nephrostomy and enterostomy tubes and urinary catheters. It offers straightforward advice about these frequent problems.
Eye infections are common among emergency department (ED) pediatric patients and can lead to significant morbidity if not properly managed.
